Approval · Notice of Compliance 5819 · 1994
PULMOZYME: Notice of Compliance 5819
Issued September 8, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5819
- Date
- September 8, 1994
- Company
- Genentech Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Enzyme
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PULMOZYME | 02046733 | Marketed |
Medicinal ingredients
- DORNASE ALFA 1 MG per ML